This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Leibniz-Institut Fur Analytische Wissenschaften - Isas - E.v.. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Innovations by Juliet Padden in Cholangiocellular Carcinoma Research
Introduction
Juliet Padden is a notable inventor based in Bochum, Germany. She has made significant contributions to the field of medical research, particularly in the identification of biomarkers for cholangiocellular carcinoma (CCC). Her work is crucial for advancing diagnostic and therapeutic methods for this challenging disease.
Latest Patents
Juliet Padden holds 1 patent related to her innovative research. The patent focuses on a method for identifying specific marker proteins, or biomarkers, for cholangiocellular carcinoma. This invention not only identifies these biomarkers but also outlines their use in diagnosis, surveillance, and treatment of CCC. Additionally, it includes a diagnostic device that utilizes these biomarkers in a screening assay to identify novel pharmaceutical compounds for treating CCC.
Career Highlights
Juliet Padden is affiliated with the Leibniz Institute for Analytical Sciences (ISAS) in Germany. Her work at this prestigious institution has allowed her to collaborate with other talented researchers and contribute to significant advancements in cancer diagnostics.
Collaborations
Some of her notable coworkers include Thilo Bracht and Dominik Megger. Their collaborative efforts have further enhanced the research and development of innovative solutions in the field of cholangiocellular carcinoma.
Conclusion
Juliet Padden's contributions to the identification of biomarkers for cholangiocellular carcinoma represent a significant advancement in medical research. Her innovative work has the potential to improve diagnosis and treatment options for patients suffering from this disease.